The effect of the leucopyrokinin analogue: [2-8]-leucopyrokinin on central opioid receptors in rats.
The antinociceptive effect of intracerebroventricular injections of [2-8]-leucopyrokinin (LPK), a truncated leucopyrokinin analogue, was determined in rats, by means of a tail immersion test. We found a significant antinociceptive effect of three i.c.v. doses of [2-8]-LPK: 1, 5 and 10 nmol. Pre-treating animals with naloxone hydrochloride (1 mg/kg i.p.) completely blocked the effect of two high doses of [2-8]-LPK. To determine the sub-types of opioid receptors involved in [2-8]-leucopyrokinin-induced analgesia we injected specific blockers of mu-, delta- and kappa-receptors namely, beta-funaltrexamine hydrochloride, naltrindole hydrochloride and nor-binaltorphimine dihydrochloride, respectively, prior to [2-8]-leucopyrokinin at equimolar doses. We conclude that the antinociceptive effect of [2-8]-leucopyrokinin is mediated mainly by central mu- and delta-opioid receptors.